We are live on ! Find out more
FVFI

Flagship Ventures Fund IV Portfolio holdings

AUM $382M
This Fund
S&P 500
This Quarter Est. Return
-24.11%
1 Year Est. Return
–
3 Year Est. Return
–
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$382M
AUM Growth
–
Cap. Flow
+$375M
Cap. Flow %
98.23%
Top 10 Hldgs %
100%
Holding
3
New
3
Increased
–
Reduced
–
Closed
–
Avg Time Held
0 years
Top 10 Avg Time Held
0 years
Top 20 Avg Time Held
0 years

Top Buys

Rank Stock Value
1
MCRB icon
Seres Therapeutics
MCRB
+$368M
2
TTOO icon
T2 Biosystems, Inc
TTOO
+$6.54M
3
CARM icon
Carisma Therapeutics
CARM
+$1.01M

Top Sells

No sells this quarter

Sector Composition

Rank Sector Weight
1 Healthcare 100%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow Held Since
MCRB icon
1
Seres Therapeutics
MCRB
$24.7M
$374M 97.96%
+704,179
New +$368M
2016 Q1
0 quarters
TTOO icon
2
DELISTED
T2 Biosystems, Inc
TTOO
$7.31M 1.92%
+148
New +$6.54M
2016 Q1
0 quarters
CARM icon
3
DELISTED
Carisma Therapeutics
CARM
$469K 0.12%
+73,321
New +$1.01M
2016 Q1
0 quarters

Similar funds

HC
HHG & Company Darien, Connecticut $360M AUM 2.45% 1-Year Est. Return
IUAM
Itau USA Asset Management New York $410M AUM 3.05% 1-Year Est. Return
GWM
Gupta Wealth Management San Diego, California $427M AUM 0.52% 1-Year Est. Return
CK
Carnick & Kubik Colorado Springs, Colorado $334M AUM 1.52% 1-Year Est. Return
SHA
Smith Hayes Advisers Lincoln, Nebraska $491M AUM 0.17% 1-Year Est. Return
SAS
Spectrum Advisory Services Atlanta, Georgia $255M AUM 4.81% 1-Year Est. Return
EIM
Emerson Investment Management Boston, Massachusetts $528M AUM 1.16% 1-Year Est. Return
SHG
Seven Harbour Global New York $235M AUM

Flagship Ventures Fund IV's Q1 2016 Portfolio in Review

Q1 2016 is the first quarter with a 13F filing on record for Flagship Ventures Fund IV, which disclosed 3 positions worth $382M. Its ten largest holdings account for 100% of the portfolio.

Its largest position is Seres Therapeutics: 704,179 shares worth $374M.

By sector, the portfolio is most concentrated in Healthcare at 100% of assets.

  • Flagship Ventures Fund IV's largest Q1 2016 buy was Seres Therapeutics: 704,179 shares worth $374M.
  • Flagship Ventures Fund IV's ten largest holdings make up 100% of its $382M portfolio in Q1 2016.
  • Flagship Ventures Fund IV disclosed 3 positions in Q1 2016, its first 13F filing on record.

Based on Flagship Ventures Fund IV's 13F filing for Q1 2016, filed 13 May 2016.